首页> 外国专利> USE OF GLYCYRRHETINIC ACID, GLYCYRRHIZIC ACID AND RELATED COMPOUNDS FOR MITIGATION AND/OR TREATMENT OF PNEUMONITIS/PNEUMONIA/PULMONARY FIBROSIS INDUCED BY VIRUS INFECTION AND/OR BY CHEMICAL OR BIOLOGICAL AGENTS

USE OF GLYCYRRHETINIC ACID, GLYCYRRHIZIC ACID AND RELATED COMPOUNDS FOR MITIGATION AND/OR TREATMENT OF PNEUMONITIS/PNEUMONIA/PULMONARY FIBROSIS INDUCED BY VIRUS INFECTION AND/OR BY CHEMICAL OR BIOLOGICAL AGENTS

机译:使用甘草酸,甘草酸和相关化合物的缓解和/或治疗病毒感染诱导的肺炎/肺纤维化和/或化学或生物药物诱导的肺炎/肺纤维化

摘要

The present invention pertains to novel uses of glycyrrhetinic acid (GA), glycyrrhizic acid (GR) and related compounds for mitigation and/or treatment of pneumonitis/pneumonia/pulmonary fibrosis induced by various chemicals/bioagents and/or pathogens, such as anti-cancer therapies and/or virus.;Also embodied are therapeutic uses of prodrugs, metabolites, derivatives (e.g., acids, esters and ethers), and salts of glycyrrhetinic acid (GA) and glycyrrhizic acid (GR) in a form of drugs, health products, foods or food additives.
机译:本发明涉及甘草酸(Ga),甘草酸(GR)和相关化合物的新用途,用于缓解和/或治疗各种化学品/生物和/或病原体诱导的肺炎/肺纤维化的肺炎/肺纤维化,如抗 - 癌症疗法和/或病毒。;也体现了前药,代谢物,衍生物(例如酸,酯和醚)的治疗用途,以及甘草酸(Ga)和甘草酸(GR)的甘草酸(GR)以药物,健康的形式 产品,食品或食品添加剂。

著录项

  • 公开/公告号US2021244691A1

    专利类型

  • 公开/公告日2021-08-12

    原文格式PDF

  • 申请/专利权人 LURONG ZHANG;

    申请/专利号US202117170388

  • 发明设计人 LURONG ZHANG;

    申请日2021-02-08

  • 分类号A61K31/19;A61K31/704;A61P31/14;

  • 国家 US

  • 入库时间 2022-08-24 20:34:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号